8 results match your criteria: "China zhong.yunshi@zs-hospital.sh.cn.[Affiliation]"
Gut
February 2025
Zhongshan Hospital Fudan University, Shanghai, China
Gut
February 2025
Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital Fudan University, Shanghai, China
Surg Endosc
June 2024
Zhongshan Hospital, Fudan University, Shanghai, China.
Background And Aims: Many studies of gastric gastrointestinal stromal tumors (g-GISTs) following endoscopic resection (ER) have typically focused on tumor size, with most tumors at low risk of aggressiveness after risk stratification. There have been few systematic studies on the oncologic outcomes of intermediate- or high-risk g-GISTs after ER.
Methods: From January 2014 to January 2020, we retrospectively collected patients considered at intermediate- or high-risk of g-GISTs according to the modified NIH consensus classification system.
World J Gastrointest Oncol
December 2023
Endoscopy Center, Zhongshan Hospital Fudan University, Shanghai 200032, China.
Background: Gastric subepithelial tumors (SETs) may harbor potential malignancy. Although it is well recognized that large SETs should be resected, the precise treatment strategy remains controversial. Compared to surgical resection, endoscopic resection (ER) has many advantages; however, ER of SETs in the cardia is challenging.
View Article and Find Full Text PDFNat Chem
January 2024
Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Institutes of Biomedical Sciences, Fudan University Shanghai Cancer Center, Shanghai Stomatological Hospital, and Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Biomarker discovery is essential for the understanding, diagnosis, targeted therapy and prognosis assessment of malignant diseases. However, it remains a huge challenge due to the lack of sensitive methods to identify disease-specific rare molecules. Here we present MORAC, molecular recognition based on affinity and catalysis, which enables the effective identification of candidate biomarkers with low abundance.
View Article and Find Full Text PDFWorld J Gastrointest Oncol
May 2023
Endoscopy Center, Zhongshan Hospital of Fudan University, Shanghai 200030, China.
Background: Improved adenoma detection at colonoscopy has decreased the risk of developing colorectal cancer. However, whether image-enhanced endoscopy (IEE) further improves the adenoma detection rate (ADR) is controversial.
Aim: To compare IEE with white-light imaging (WLI) endoscopy for the detection and identification of colorectal adenoma.
Surg Endosc
May 2017
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Background: To retrospectively investigate the clinicopathological features and prognosis of early esophageal squamous cell neoplasm (ESCN) treated with endoscopic resection (ER), especially, to compare the prognosis in patients with sm2 cancer and non-sm2 cancer.
Methods: From 2007 to 2013, 368 patients were included in our analysis.
Results: The patients were 252 (68.
Int J Colorectal Dis
March 2016
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Backgroud: The efficacy and safety of self-expandable metallic stents (SEMSs) as a bridge for patients with acute malignant colorectal obstructions (AMCOs) are still controversial. We conducted this study to evaluate the outcomes of patients with AMCOs treated by different strategies.
Methods: From January 2010 to March 2014, a total of 171 patients with AMCOs from Zhongshan Hospital were retrospectively enrolled in this study.